ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Treatment Choice and Cardiovascular Risk in Chronic Spontaneous Urticaria

Study limitation reported by the research below: “Reciprocal exclusion of oCS after index may have selected a more stable, less severe omalizumab-treated population, inflating the apparent cardiovascular benefit of omalizumab.”

Papers